Carbidopa 50 MG Levodopa 200 MG Extended Release Oral Tablet Sinemet

INDICATIONS AND USAGE SINEMET CR is indicated in the treatment of Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.

Merck Sharp & Dohme Corp.

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] pain` `[3] fatigue` `[4] off label use` `[5] rash` `[6] rheumatoid arthritis` `[7] abdominal discomfort` `[8] alopecia` `[9] systemic lupus erythematosus` `[10] toxicity to various agents`

4 years ago

OVAL PURPLE 521

HOW SUPPLIED No. 3919 — SINEMET CR 50-200 (carbidopa levodopa) Sustained-Release Tablets containing 50 mg of carbidopa and 200 mg of levodopa, are dappled-purple in color, oval, compressed tablets, that are coded "521" on one side and plain on the other. They are supplied as follows: NDC 0006-3919-68 bottles of 100. No. 3918 — SINEMET CR 25-100 (carbidopa levodopa) Sustained-Release Tablets containing 25 mg of carbidopa and 100 mg of levodopa, are dappled-purple in color, oval, compressed tablets, that are coded "601" on one side and plain on the other. They are supplied as follows: NDC 0006-3918-68 bottles of 100. Storage and Handling Store at 25°C (77°F), excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature]. Store in a tightly closed container, protected from light and moisture. Dispense in a tightly closed, light-resistant container.

More pills like OVAL 521

Related Pills

Carbidopa 25 MG Levodopa 100 MG Extended Release Oral Tablet Sinemet

Merck Sharp & Dohme Corp.

Promethazine Hydrochloride Promethazine Hydrochloride 25 MG Oral Tablet

REMEDYREPACK INC.

Promethazine Hydrochloride Promethazine Hydrochloride 25 MG Oral Tablet

Amneal Pharmaceuticals

promethazine hydrochloride tablet

amneal pharmaceuticals, llc

promethazine hydrochloride tablet

amneal pharmaceuticals llc

promethazine hydrochloride tablet

amneal pharmaceuticals llc

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site